Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Historical epidemiology of hepatitis C virus (HCV) in selected countries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Strategies to manage hepatitis C virus (HCV) disease burden

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Syphilitic hepatitis and neurosyphilis: an observational study of Danish HIV-infected individuals during a 13-year period

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. HIV infection is independently associated with a higher concentration of alpha-1 antitrypsin

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • H Razavi
  • I Waked
  • C Sarrazin
  • R P Myers
  • R Idilman
  • F Calinas
  • W Vogel
  • M C Mendes Correa
  • C Hézode
  • P Lázaro
  • U Akarca
  • S Aleman
  • I Balık
  • T Berg
  • F Bihl
  • M Bilodeau
  • A J Blasco
  • C E Brandão Mello
  • P Bruggmann
  • M Buti
  • J L Calleja
  • H Cheinquer
  • P B Christensen
  • M Clausen
  • H S M Coelho
  • M E Cramp
  • G J Dore
  • W Doss
  • A S Duberg
  • M H El-Sayed
  • G Ergör
  • G Esmat
  • K Falconer
  • J Félix
  • M L G Ferraz
  • P R Ferreira
  • S Frankova
  • J García-Samaniego
  • J Gerstoft
  • J A Giria
  • F L Gonçales
  • E Gower
  • M Gschwantler
  • M Guimarães Pessôa
  • S J Hindman
  • H Hofer
  • P Husa
  • M Kåberg
  • K D E Kaita
  • A Kautz
  • S Kaymakoglu
  • M Krajden
  • H Krarup
  • W Laleman
  • D Lavanchy
  • R T Marinho
  • P Marotta
  • S Mauss
  • C Moreno
  • K Murphy
  • F Negro
  • V Nemecek
  • N Örmeci
  • A L H Øvrehus
  • J Parkes
  • K Pasini
  • K M Peltekian
  • A Ramji
  • N Reis
  • S K Roberts
  • W M Rosenberg
  • F Roudot-Thoraval
  • S D Ryder
  • R Sarmento-Castro
  • D Semela
  • M Sherman
  • G E Shiha
  • W Sievert
  • J Sperl
  • P Stärkel
  • R E Stauber
  • A J Thompson
  • P Urbanek
  • P Van Damme
  • I van Thiel
  • H Van Vlierberghe
  • D Vandijck
  • H Wedemeyer
  • N Weis
  • J Wiegand
  • A Yosry
  • A Zekry
  • M Cornberg
  • B Müllhaupt
  • C Estes
Vis graf over relationer

The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modelling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. In addition, the model was used to estimate the change in the total number of HCV infections, the disease progression and mortality in 2013-2030. Finally, expert panel consensus was used to capture current treatment practices in each country. Using today's treatment paradigm, the total number of HCV infections is projected to decline or remain flat in all countries studied. However, in the same time period, the number of individuals with late-stage liver disease is projected to increase. This study concluded that the current treatment rate and efficacy are not sufficient to manage the disease burden of HCV. Thus, alternative strategies are required to keep the number of HCV individuals with advanced liver disease and liver-related deaths from increasing.

OriginalsprogEngelsk
TidsskriftJournal of Viral Hepatitis
Vol/bind21 Suppl 1
Sider (fra-til)34-59
Antal sider26
ISSN1352-0504
DOI
StatusUdgivet - maj 2014

ID: 45003996